✦ LIBER ✦

Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia

✍ Scribed by DiNardo, C. D.; Propert, K. J.; Loren, A. W.; Paietta, E.; Sun, Z.; Levine, R. L.; Straley, K. S.; Yen, K.; Patel, J. P.; Agresta, S.; Abdel-Wahab, O.; Perl, A. E.; Litzow, M. R.; Rowe, J. M.; Lazarus, H. M.; Fernandez, H. F.; Margolis, D. J.; Tallman, M. S.; Luger, S. M.; Carroll, M.

Book ID: 121346164
Publisher: American Society of Hematology
Year: 2013
Tongue: English
Weight: 991 KB
Volume: 121
Category: Article
ISSN: 0006-4971
DOI: 10.1182/blood-2013-03-493197

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The prognostic impact and stability of I

The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia

✍ Chou, W-C; Lei, W-C; Ko, B-S; Hou, H-A; Chen, C-Y; Tang, J-L; Yao, M; Tsay, W; W 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 437 KB

Prognostic Impact of Isocitrate Dehydrog

Prognostic Impact of Isocitrate Dehydrogenase Enzyme Isoforms 1 and 2 Mutations in Acute Myeloid Leukemia: A Study by the Acute Leukemia French Association Group

✍ Boissel, N.; Nibourel, O.; Renneville, A.; Gardin, C.; Reman, O.; Contentin, N.; 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 274 KB

Serum 2-Hydroxyglutarate Production in I

Serum 2-Hydroxyglutarate Production in IDH1- and IDH2-Mutated De Novo Acute Myeloid Leukemia: A Study by the Acute Leukemia French Association Group

✍ Janin, M.; Mylonas, E.; Saada, V.; Micol, J.-B.; Renneville, A.; Quivoron, C.; K 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 350 KB

Molecular alterations of isocitrate dehy

Molecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1andIDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients

✍ Sadudee Chotirat; Wanna Thongnoppakhun; Orathai Promsuwicha; Chetsada Boonthimat 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 574 KB

Pretransplant minimal residual disease l

Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation

✍ Venditti, A; Maurillo, L; Buccisano, F; Del Poeta, G; Mazzone, C; Tamburini, A; 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 152 KB

Pretransplant minimal residual disease l

Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation

✍ Venditti, A; Maurillo, L; Buccisano, F; Del Poeta, G; Mazzone, C; Tamburini, A; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 27 KB